Neurodegenerative diseases are characterised by neuronal damage, degradation of the blood-brain barrier and failures in the normal repair mechanisms of the brain. Many of the most promising areas of drug development in this field target neuroinflammation and remyelination.
In this on-demand webinar, presented by Dr Elise Malavasi, Principal Scientist at Concept Life Sciences, we use multiple sclerosis as a case-study of a neurodegenerative disease, so you can:
- Understand the key processes in neurodegeneration
- Discover how in vitro assays can be used to model in vivo neurodegeneration
- Learn how to select the most appropriate assay for your drug target of interest